More Opposition for Medicare Part B Drug Plan

Just days after the Obama administration unveiled an experiment to revamp the Medicare Part B program, more than 300 hundred groups representing physicians, drug makers, and patients are urging the government to withdraw its proposal.

Although some details must still be worked out, the administration wants to encourage greater use of lower-cost, but equally effective treatments. The Part B program covers injectable and infused medications for the elderly. The government also maintains its plan will be budget-neutral, or will not cost additional money.